New Alzheimer's Drug Also Helps Combat Diabetes And Heart Disease!
Galantamine has previously been used to combat the symptoms of Alzheimer's Disease, a disease which affects memory and other important mental functions. However, researchers are now stating that the drug may actually lower the risk of type 2 diabetes and heart disease.
According to the research conducted by Valentin A. Pavlov, Ph.D. and his team at Northwell, the drug accomplishes this by fighting metabolic syndrome.
What Is Metabolic Syndrome?
Metabolic syndrome is a cluster of abnormalities which have been associated with the development of cardiovascular disease and type 2 diabetes. This includes high blood sugar, hypertension, excess body fat in the waistline, and abnormal cholesterol levels. Whether compiled or stand-alone, all of these abnormalities increase the risk for heart disease, stroke, and diabetes.
Currently, there is no drug approved by the FDA to combat this syndrome. Doctors have been managing individual components with prescripted medications and lifestyle changes which are meant to ease symptoms.
New Research Provides Hope
The recent study into the Alzheimer's drug Galantamine may be able to ease the overall syndrome. The study, which was published in JCI Insight, stated that the drug contains anti-inflammatory properties, which researchers believe will help those suffering from metabolic syndrome. During the study, it was discovered that Galantamine affects the nervous system, particularly the vagus nerve. This system alters metabolic and digestive processes, as well as swaying inflammation levels in the body.
The drug is now being considered for repurposing. As the medication has been on the market for some time, it has been previously been approved for use by the FDA. This means the drug will not have to undergo any further trials to determine safety.